Aarti Pharmalabs Financials
NSE: AARTIPHARM | BSE: 543748
₹919.75
₹-0.20
(-0.02%)
As on 04-Nov-2026 11:54IST
Market cap
₹8,366 Cr
Revenue (TTM)
₹2,161 Cr
P/E Ratio
32.6
P/B Ratio
3.7
Div. Yield
0.4 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
2,161.17
|
1,819.44
|
2,115.07
|
1,852.61
|
1,945.23
|
1,199.94
|
|
|
|
|
|
|
Total Income
|
2,169.77
|
1,829.19
|
2,125.19
|
1,857.50
|
1,947.55
|
1,204.13
|
|
|
|
|
|
|
Total Expenditure
|
1,674.46
|
1,450.23
|
1,650.70
|
1,466.56
|
1,603.18
|
994.67
|
|
|
|
|
|
|
EBITDA
|
486.71
|
369.21
|
464.37
|
386.05
|
342.05
|
205.27
|
|
|
|
|
|
|
Depreciation
|
117.33
|
104.34
|
86.90
|
73.24
|
62.54
|
42.12
|
|
|
|
|
|
|
EBIT
|
369.38
|
264.87
|
377.47
|
312.81
|
279.51
|
163.15
|
|
|
|
|
|
|
Interest
|
57.27
|
46.90
|
26.90
|
17.21
|
21.05
|
11.96
|
|
|
|
|
|
|
Other Income
|
8.60
|
9.75
|
10.12
|
4.90
|
2.32
|
4.19
|
|
|
|
|
|
|
Exceptional Items
|
-4.84
|
-2.79
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Profit before Tax
|
315.87
|
232.92
|
360.69
|
300.49
|
260.77
|
155.38
|
|
|
|
|
|
|
Provision for Tax
|
83.90
|
58.21
|
88.28
|
83.59
|
67.28
|
33.13
|
|
|
|
|
|
|
Profit after Tax
|
231.97
|
174.71
|
272.40
|
216.90
|
193.49
|
122.25
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Share of Associate
|
24.72
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
256.70
|
174.71
|
272.40
|
216.90
|
193.49
|
122.25
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
2,254.77
|
2,124.60
|
1,989.91
|
1,757.04
|
1,558.49
|
1,386.48
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
311.57
|
419.53
|
259.45
|
130.68
|
84.91
|
72.76
|
|
|
|
|
|
|
Current Liabilities
|
1,259.54
|
937.57
|
653.07
|
694.39
|
600.62
|
580.67
|
|
|
|
|
|
|
Total Liabilities
|
3,825.88
|
3,481.71
|
2,902.43
|
2,582.11
|
2,244.02
|
2,039.90
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
2,067.79
|
2,084.41
|
1,584.24
|
1,236.46
|
1,081.02
|
1,011.75
|
|
|
|
|
|
|
Current Assets
|
1,656.55
|
1,397.29
|
1,318.19
|
1,345.64
|
1,163.01
|
1,028.15
|
|
|
|
|
|
|
Total Assets
|
3,825.88
|
3,481.71
|
2,902.43
|
2,582.11
|
2,244.02
|
2,039.90
|
|
|
|
|
|
|
Total Debt*
|
--
|
685.63
|
396.35
|
264.10
|
214.34
|
338.62
|
|
|
|
|
|
|
Net Current Assets
|
397.01
|
459.72
|
665.12
|
651.25
|
562.38
|
447.48
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
7.94
|
13.91
|
7.19
|
6.86
|
--
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
261.93
|
330.14
|
216.35
|
250.12
|
-43.70
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-430.72
|
-412.48
|
-214.56
|
-157.80
|
-138.74
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
170.58
|
65.43
|
9.72
|
-163.46
|
260.39
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
1.80
|
-16.90
|
11.51
|
-71.15
|
77.94
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
28.75
|
19.27
|
30.06
|
23.93
|
21.35
|
4,890.04
|
|
|
|
|
|
|
Cash EPS (₹)
|
28.31
|
30.78
|
39.64
|
32.01
|
28.25
|
6,574.79
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
248.65
|
234.02
|
219.36
|
193.85
|
171.97
|
53,646.60
|
|
|
|
|
|
|
Dividend per Share (₹)
|
0.38
|
3.50
|
5.00
|
3.00
|
2.00
|
--
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
28.89
|
36.43
|
23.87
|
27.60
|
-1,748.15
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
-30.47
|
-18.85
|
-3.37
|
13.49
|
-8,285.82
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
10.77
|
17.59
|
16.75
|
16.11
|
19.40
|
|
|
|
|
|
|
ROE (%)
|
11.90
|
8.50
|
14.55
|
13.08
|
13.35
|
18.23
|
|
|
|
|
|
|
ROA (%)
|
6.54
|
5.47
|
9.93
|
8.99
|
9.03
|
11.98
|
|
|
|
|
|
|
EBIT Margin (%)
|
17.09
|
14.56
|
17.85
|
16.88
|
14.37
|
13.60
|
|
|
|
|
|
|
Net Margin (%)
|
10.69
|
9.55
|
12.82
|
11.68
|
9.94
|
10.15
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
15.34
|
16.99
|
15.66
|
13.16
|
13.70
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
13.38
|
-13.98
|
14.17
|
-4.76
|
62.11
|
--
|
|
|
|
|
|
|
EBIT Growth (%)
|
10.54
|
-29.83
|
20.67
|
11.91
|
71.32
|
35,46,839.13
|
|
|
|
|
|
|
Net Profit Growth (%)
|
13.90
|
-35.86
|
25.59
|
12.10
|
58.28
|
--
|
|
|
|
|
|
|
EPS Growth (%)
|
12.12
|
-35.88
|
25.58
|
12.10
|
-99.56
|
--
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
6.71
|
13.17
|
12.73
|
16.20
|
5,87,872.38
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
32.59
|
30.58
|
24.91
|
18.18
|
12.86
|
--
|
|
|
|
|
|
|
Price / Book Value
|
3.71
|
2.52
|
3.41
|
2.24
|
1.60
|
--
|
|
|
|
|
|
|
Dividend Yield (%)
|
0.38
|
0.59
|
0.67
|
0.69
|
0.73
|
--
|
|
|
|
|
|
|
EV/EBITDA
|
18.53
|
15.88
|
15.12
|
10.70
|
7.81
|
1.22
|
|
|
|
|
|
|
Close Price (₹)
|
953.75
|
591.95
|
749.25
|
434.95
|
275.85
|
--
|
|
|
|
|
|
|
High Price (₹)
|
1,002.40
|
971.50
|
837.25
|
594.90
|
397.00
|
--
|
|
|
|
|
|
|
Low Price (₹)
|
583.85
|
557.20
|
429.50
|
269.00
|
234.80
|
--
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
8,365.67
|
5,342.07
|
6,784.52
|
3,942.17
|
2,489.12
|
--
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.07
|
0.32
|
0.20
|
0.15
|
0.14
|
0.25
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
0.22
|
0.15
|
0.15
|
0.14
|
0.24
|
|
|
|
|
|
|
Current Ratio
|
1.32
|
1.49
|
2.02
|
1.94
|
1.94
|
1.77
|
|
|
|
|
|
|
Quick Ratio
|
0.68
|
0.81
|
1.12
|
1.01
|
0.93
|
0.95
|
|
|
|
|
|
|
Interest Coverage
|
6.52
|
5.97
|
14.41
|
18.46
|
13.39
|
13.99
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
31.69
|
32.06
|
27.20
|
28.03
|
23.14
|
31.39
|
|
|
|
|
|
|
Asset Turnover
|
0.61
|
0.57
|
0.77
|
0.77
|
0.91
|
1.18
|
|
|
|
|
|
|
Receivable days
|
--
|
116.23
|
94.46
|
95.50
|
77.57
|
114.57
|
|
|
|
|
|
|
Inventory Days
|
--
|
123.16
|
106.17
|
122.63
|
101.09
|
144.62
|
|
|
|
|
|
|
Payable days
|
--
|
133.87
|
111.22
|
128.34
|
86.45
|
61.41
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
105.52
|
89.41
|
89.79
|
92.21
|
197.78
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
